B7-H3/CD276 and small-cell lung cancer: What's new?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

B7-H3/CD276 and small-cell lung cancer: What's new?

Published:2024-01 Issue: Volume:39 Page:101801
ISSN:1936-5233
Container-title:Translational Oncology
language:en
Short-container-title:Translational Oncology

Author:

Fabrizio Federico Pio^ORCID,Muscarella Lucia Anna,Rossi Antonio

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference57 articles.

1. Regulatory mechanisms of immune checkpoints PD-L1 and CTLA-4 in cancer;Zhang;J. Exp. Clin. Cancer Res.,2021

2. First-line atezolizumab plus chemotherapy in extensive-stage small-cell lung cancer;Horn;N. Engl. J. Med.,2018

3. Durvalumab plus platinum-etoposide versus platinum-etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial;Paz-Ares;Lancet,2019

4. Acquired resistance to immune checkpoint inhibitors;Schoenfeld;Cancer Cell,2020

5. Novel immune checkpoint targets: moving beyond PD-1 and CTLA-4;Qin;Mol. Cancer,2019

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Editorial: Co-inhibitory immune checkpoint proteins as biomarkers and therapeutic targets in cancer;Translational Oncology;2024-09

2. DB-1314, a novel DLL3-targeting ADC with DNA topoisomerase I inhibitor, exhibits promising safety profile and therapeutic efficacy in preclinical small cell lung cancer models;Journal of Translational Medicine;2024-08-14

3. Small cell lung cancer: emerging subtypes, signaling pathways, and therapeutic vulnerabilities;Experimental Hematology & Oncology;2024-08-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3